Discover
ADVB
Advanced Biomed Inc. Common Stock
7.29
1 x 7.28
1 x 7.81
bid
ask
-
1.61
18.09%
12:10 PM
timesize
| Ytd | 24.83% | |
| 1y | -43.22% |
7.00
day range
8.90
3.71
52 week range
12.84
| Open | 8.24 | Prev Close | 8.90 | Low | 7.00 | High | 8.90 | Mkt Cap | 9.63M |
| Vol | 1.46M | Avg Vol | 156.26K | EPS | -0.11 | P/E | -80.91 | Forward P/E | N/A |
| Beta | 0.52 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 4.75 | 200-d Avg | 6.17 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 519.84K | ||
| Research and Development Expense | 243.23K | ||
| Selling, General and Administrative Expense | 276.61K | ||
| Operating Income | -519.84K | ||
| Interest Expense | 112.00 | ||
| Net Income | -488.94K | ||
| Net Income Common Stock | -488.94K | ||
| Net Income Common Stock (USD) | -488.94K | ||
| Consolidated Income | -488.94K | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -488.83K | ||
| Earning Before Interest & Taxes (USD) | -488.83K | ||
| Weighted Average Shares | 1.28M | ||
| Weighted Average Shares Diluted | 1.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.60M | ||
| Cash and Equivalents (USD) | 2.60M | ||
| Current Assets | 10.53M | ||
| Property, Plant & Equipment Net | 117.83K | ||
| Total Assets | 10.65M | ||
| Debt Current | 18.61K | ||
| Total Debt | 29.51K | ||
| Current Liabilities | 1.43M | ||
| Debt Non-Current | 10.90K | ||
| Total Liabilities | 1.44M | ||
| Accumulated Retained Earnings (Deficit) | -13.25M | ||
| Accumulated Other Comprehensive Income | 843.79K | ||
| Shareholders Equity | 9.21M | ||
| Shareholders Equity (USD) | 9.21M | ||
| Assets Non-Current | 120.02K | ||
| Total Debt (USD) | 29.51K | ||
| Liabilities Non-Current | 10.90K | ||
| Trade and Non-Trade Payables | 1.41M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.33K | ||
| Net Cash Flow from Financing | 268.28K | ||
| Capital Expenditure | -1.26K | ||
| Issuance (Purchase) of Equity Shares | 248.00K | ||
| Issuance (Repayment) of Debt Securities | 20.28K | ||
| Net Cash Flow from Investing | -1.26K | ||
| Net Cash Flow from Operations | -239.77K | ||
| Effect of Exchange Rate Changes on Cash | -29.21K | ||